Mechanisms of Action of AGuIX as a Pan-Cancer Nano-Radiosensitizer: A Comprehensive Review
Clémentine Fulbert,
No information about this author
Tristan Doussineau,
No information about this author
Léna Carmès
No information about this author
et al.
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(4), P. 519 - 519
Published: April 2, 2025
Objective:
This
review
provides
an
overview
of
the
current
knowledge
regarding
mechanisms
action
AGuIX,
a
clinical-stage
theranostic
nano-radiosensitizer
composed
gadolinium.
It
covers
steps
following
administration,
from
internalization
in
tumor
cells
to
interaction
with
X-rays
and
subsequent
physical,
chemical,
biological,
immunological
events.
Results:
After
intravenous
injection,
AGuIX
accumulates
tumors
through
enhanced
permeability
retention
(EPR)
effect,
its
specific
properties
allow
persistence
for
several
days.
At
cellular
level,
nanomedicine
is
internalized
by
endocytic
processes
mainly
located
cytoplasm,
especially
lysosomes.
enhances
effects
radiotherapy
(RT)
at
levels,
starting
radiation–matter
interactions
chemical
stage
reactive
oxygen
species
(ROS)
production,
followed
cascade
biological
events
leading
cell
death
immune
response.
Indeed,
induces
local
increase
radiation
dose
deposition
emission
Auger
electrons,
ROS
generation.
also
impacts
RT-induced
mechanisms,
including
DNA
damage
such
as
apoptosis,
autophagic
death,
ferroptosis.
Last,
combination
RT
stimulates
antitumor
response
induction
immunogenic
(ICD),
activation
dendritic
T
cells,
reprogramming
tumor-associated
macrophages
(TAMs)
into
pro-inflammatory
phenotype.
Conclusions:
nanoparticle
(NP)
intravenously
administered
pan-cancer
potential
due
biodistribution
strong
ability
amplify
mechanisms.
Language: Английский
Autofluorescence cascade nanozyme catalyzes in vivo ROS scavenging for precisive anti-neuroinflammation therapy
Xiyu Du,
No information about this author
Gang Zhao,
No information about this author
Yifei Fu
No information about this author
et al.
Chemical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
unknown, P. 163217 - 163217
Published: May 1, 2025
Nanoscale dosimetry for a radioisotope‐labeled metal nanoparticle using MCNP6.2 and Geant4
Taeyun Kim,
No information about this author
Rodrigo Hernández Millares,
No information about this author
Tae‐Wan Kim
No information about this author
et al.
Medical Physics,
Journal Year:
2024,
Volume and Issue:
51(12), P. 9290 - 9302
Published: Sept. 3, 2024
Metal
nanoparticles
(MNPs)
labeled
with
radioisotopes
(RIs)
are
utilized
as
radio-enhancers
due
to
their
ability
amplify
the
radiation
dose
in
immediate
vicinity.
A
thorough
understanding
of
nanoscale
dosimetry
around
MNPs
enables
effective
application
radiotherapy.
However,
still
requires
further
investigation.
Language: Английский